Temporal expression of transporters and receptors in a rat primary co-culture blood–brain barrier model

References

• Azhar S, Medicherla S, Shen WJ, et al. (2006). LDL and cAMP cooperate to regulate the functional expression of the LRP in rat ovarian granulosa cells. J Lipid Res 47:2538–50
   Google Scholar
• Boado RJ, Pardridge WM. (1994). Measurement of blood-brain barrier GLUT1 glucose transporter and actin mRNA by a quantitative polymerase chain reaction assay. J Neurochem 62:2085–90
   PubMed Web of Science ®Google Scholar
• Barrand MA, Robertson KJ, von Weikersthal SF. (1995). Comparisons of P-glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta. FEBS Lett 374:179–83
   PubMed Web of Science ®Google Scholar
• Campbell SD, Regina KJ, Kharasch ED. (2013). Significance of lipid composition in a blood-brain barrier–mimetic pampa assay. J Biomol Screen 19:437–44
   Google Scholar
• Chow EC, Sun H, Khan AA, et al. (2010). Effects of 1alpha,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo. Biopharm Drug Dispos 31:91–108
   PubMed Web of Science ®Google Scholar
• Cucullo L, Aumayr B, Rapp E, Janigro D. (2005). Drug delivery and in vitro models of the blood-brain barrier. Curr Opin Drug Discov Dev 8:89–99
   PubMed Web of Science ®Google Scholar
• Dauchy S, Dutheil F, Weaver RJ, et al. (2008). ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 107:1518–28
   PubMed Web of Science ®Google Scholar
• De Boer AG, Gaillard PJ. (2002). In vitro models of the blood-brain barrier: when to use which? Curr Med Chem Central Nervous System Agents 2:203–9
   Google Scholar
• Demeuse P, Kerkhofs A, Struys-Ponsar C, et al. (2002). Compartmentalized coculture of rat brain endothelial cells and astrocytes: a syngenic model to study the blood-brain barrier. J Neurosci Methods 121:21–31
   Google Scholar
• Di L, Kerns EH, Bezar IF, et al. (2009). Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB. J Pharm Sci 98:1980–91
   PubMed Web of Science ®Google Scholar
• Di L, Whitney-Pickett C, Umland JP, et al. (2011). Development of a new permeability assay using low-efflux MDCKII cells. J Pharm Sci 100:4974–85
   PubMed Web of Science ®Google Scholar
• Donahue JE, Flaherty SL, Johanson CE, et al. (2006). RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 112:405–15
   PubMed Web of Science ®Google Scholar
• Filbrandt CR, Wu Z, Zlokovic B, et al. (2004). Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes. Neurotoxicology 25:605–16
   PubMed Web of Science ®Google Scholar
• Goh LB, Spears KJ, Yao D, et al. (2002). Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man. Biochem Pharmacol 64:1569–78
   PubMed Web of Science ®Google Scholar
• Gutmann H, Török M, Fricker G, et al. (1999). Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro. Drug Metab Dispos 27:937–41
   PubMed Web of Science ®Google Scholar
• Hakkarainen JJ, Jalkanen AJ, Kaariainen TM, et al. (2010). Comparison of in vitro cell models in predicting in vivo brain entry of drugs. Int J Pharm 402:27–36
   PubMed Web of Science ®Google Scholar
• Hakkarainen JJ, Pajander J, Laitinen R, et al. (2012). Similar molecular descriptors determine the in vitro drug permeability in endothelial and epithelial cells. Int J Pharm 436:426–43
   PubMedGoogle Scholar
• Ishiguro M, Imai Y, Kohsaka S. (1995). Expression and distribution of low density lipoprotein receptor-related protein mRNA in the rat central nervous system. Brain Res Mol Brain Res 33:37–46
   PubMedGoogle Scholar
• Jorgensen L, Van Beek J, Lund S, et al. (2007). Evidence of Oatp and Mdr1 in cryopreserved rat hepatocytes. Eur J Pharm Sci 30:181–9
   PubMed Web of Science ®Google Scholar
• Kajimoto T, Okada T, Yu H, et al. (2007). Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons. Mol Cell Biol 27:3429–40
   PubMed Web of Science ®Google Scholar
• Kotnik K, Popova E, Todiras M, et al. (2009). Inducible transgenic rat model for diabetes mellitus based on shRNA-mediated gene knockdown. PLoS One 4:e5124
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Sugiyama Y. (2001). Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1). Drug Discov Today 6:150–6
   PubMed Web of Science ®Google Scholar
• Kuteykin-Teplyakov K, Luna-Tortos C, Ambroziak K, Loscher W. (2010). Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport. Br J Pharmacol 160:1453–63
   PubMed Web of Science ®Google Scholar
• Lai CH, Kuo KH. (2005). The critical component to establish in vitro BBB model: Pericyte. Brain Res Brain Res Rev 50:258–65
   PubMed Web of Science ®Google Scholar
• Lundquist S, Renftel M, Brillault J, et al. (2002). Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. Pharm Res 19:976–81
   PubMed Web of Science ®Google Scholar
• Lyck R, Ruderisch N, Moll AG, et al. (2009). Culture-induced changes in blood-brain barrier transcriptome: implications for amino-acid transporters in vivo. J Cereb Blood Flow Metab 29:1491–502
   Google Scholar
• Macias RI, Jimenez S, Serrano MA, et al. (2006). Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver. Life Sci 79:1014–19
   PubMed Web of Science ®Google Scholar
• Miller DS. (2010). Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol Sci 31:246–54
   PubMed Web of Science ®Google Scholar
• Nakagawa S, Deli MA, Kawaguchi H, et al. (2009). A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int 54:253–63
   PubMed Web of Science ®Google Scholar
• Perrière N, Demeuse P, Garcia E, et al. (2005). Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem 93:279–89
   PubMed Web of Science ®Google Scholar
• Perrière N, Yousif S, Cazaubon S, et al. (2007). A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain Res 1150:1–13
   PubMed Web of Science ®Google Scholar
• Polli J, Humphreys J, Wring S, et al. (2000). Comparison of MDCK and bovine brain endothelial cells (BBECs) as a blood-brain barrier screen in early drug discovery. In: Balls M, van Zeller A-M, Halder M, eds. Progress in the reduction, refinement and replacement of animal experimentation (s), New York: Elsevier Science, 271–89
   Google Scholar
• Raggers RJ, Vogels I, van Meer G. (2002). Upregulation of the expression of endogenous Mdr1 P-glycoprotein enhances lipid translocation in MDCK cells transfected with human MRP2. Histochem Cell Biol 117:181–5
   PubMed Web of Science ®Google Scholar
• Rautio J, Humphreys JE, Webster LO, et al. (2006). In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. Drug Metab Dispos 34:786–92
   PubMed Web of Science ®Google Scholar
• Regina A, Koman A, Piciotti M, et al. (1998). Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 71:705–15
   PubMed Web of Science ®Google Scholar
• Su T, Waxman DJ. (2004). Impact of dimethyl sulfoxide on expression of nuclear receptors and drug-inducible cytochromes P450 in primary rat hepatocytes. Arch Biochem Biophys 424:226–34
   PubMed Web of Science ®Google Scholar
• Summerfield SG, Read K, Begley DJ, et al. (2007). Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction. J Pharmacol Exp Ther 322:205–13
   PubMed Web of Science ®Google Scholar
• Tao-Cheng JH, Nagy Z, Brightman MW. (1987). Tight junctions of brain endothelium in vitro are enhanced by astroglia. J Neurosci 7:3293–9
   PubMed Web of Science ®Google Scholar
• Tran TT, Mittal A, Gales T, et al. (2004). Exact kinetic analysis of passive transport across a polarized confluent MDCK cell monolayer modeled as a single barrier. J Pharm Sci 93:2108–23
   PubMed Web of Science ®Google Scholar
• Uchino H, Kanai Y, Kim DK, et al. (2002). Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol 61:729–37
   PubMed Web of Science ®Google Scholar
• Visser CC, Voorwinden LH, Crommelin DJ, et al. (2004). Characterization and modulation of the transferrin receptor on brain capillary endothelial cells. Pharm Res 21:761–9
   PubMed Web of Science ®Google Scholar
• Wan H, Rehngren M, Giordanetto F, et al. (2007). High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. J Med Chem 50:4606–15
   PubMed Web of Science ®Google Scholar
• Wang X, Hawkins BT, Miller DS. (2011). Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. FASEB J 25:644–52
   PubMed Web of Science ®Google Scholar
• Wang X, Sykes DB, Miller DS. (2010). Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. Mol Pharmacol 78:376–83
   PubMed Web of Science ®Google Scholar
• Wu D, Pardridge WM. (1998). Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody. Drug Metab Dispos 26:937–9
   PubMed Web of Science ®Google Scholar
• Xia JR, Liu NF, Zhu NX. (2008). Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats. Int J Mol Sci 9:638–61
   Google Scholar
• Yau TM, Li G, Zhang Y, et al. (2005). Vascular endothelial growth factor receptor upregulation in response to cell-based angiogenic gene therapy. Ann Thorac Surg 79:2056–63
   PubMed Web of Science ®Google Scholar
• Yousif S, Marie-Claire C, Roux F, et al. (2007). Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy. Brain Res 1134:1–11
   Google Scholar
• Zhang Y, Li CS, Ye Y, et al. (2006). Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability. Drug Metab Dispos 34:1935–43
   PubMed Web of Science ®Google Scholar
• Zhang AS, Xiong S, Tsukamoto H, Enns CA. (2004). Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood 103:1509–14
   PubMed Web of Science ®Google Scholar